Panel Discussion – The Current Landscape of Dry AMD Therapeutics
Time: 8:00 am
day: Day One
- Reviewing complement inhibition as a means of treating dry AMD
- Outlining the promise of small molecule, cell therapy, stem cell therapy and gene therapy
- What is the earliest stage of AMD feasible for a clinical trial?